Merck to Acquire Pandion Therapeutics
Go back to Merck to Acquire Pandion Therapeutics| Merck & Co. (NYSE: MRK) | Delayed: 135.55 +2.63 (1.98%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $132.92 | 52 Week High | $65.46 | |||
| Open | $133.86 | 52 Week Low | $47.97 | |||
| Day High | $135.68 | P/E | 92.21 | |||
| Day Low | $133.06 | EPS | $1.47 | |||
| Volume | 8,894,758 | |||||
| (NASDAQ: PAND) | Delayed: 60.05 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $60.05 | 52 Week High | $ | |||
| Open | $35.76 | 52 Week Low | $ | |||
| Day High | $60.05 | P/E | N/A | |||
| Day Low | $60.05 | EPS | $ | |||
| Volume | 1,360 | |||||
